Table Of Content

international journal of — pharmaceutics F255 HH) ELSEVIER International Journal of Pharmaceutics 143 (1996) 271—272 Author index Adolfsson, A., see Olsson, H. 143, 233 Gallardo, M., see Casals, E. 143, 171 Allémann, E., see Quintanar-Guerrero, D. 143, 133 Gasco, M.R., see Trotta, M. 143, 67 Arias-Blanco, M.J., P. Mufioz, J.R. Moyano, J.M. Ginés, C. Ginés, J.M., M.J. Arias, J.R. Moyano, P.J. Sanchez-Soto, Novak, Preliminary study of different omeprazole-y-CD Thermal investigation of crystallization of polyethylene gly- co-grinded systems 143, 113 cols in solid dispersions containing oxazepam 143, 247 Arias, M.J., see Ginés, J.M. 143, 247 Ginés, J.M., see Arias-Blanco, M.J. 143, 113 Grognet, J.-M., see Ramaldes, G.A. 143, | Bakhouya, A., M. Saidna, J.M. Vergnaud, Calculation of the Gupta, P., see Qiu, Y. 143, 179 antibiotic level in the plasma with an oral erosion-controlled dosage form 143, 143 Healy, A.M., O.I. Corrigan, The influence of excipient particle Bard, J., see Wu-Pong, S. 143, 259 size, solubility and acid strength on the dissolution of an Beckert, T.E., K. Lehmann, P.C. Schmidt, Compression of acidic drug from two-component compacts 143, 211 enteric-coated pellets to disintegrating tablets 143, 13 Heng, P.W.S., L.S.C. Wan, Y.T.F. Tan, Optimization of Bondi, M., see Iannuccelli, V. 143, 187 spheroid production by centrifugal rotary processing 143, Briskin, J., see Qiu, Y. 143, 179 107 Holborow, D.W., see Medlicott, N.J. 143, 25 Cameroni, R., see Iannuccelli, V. 143, 187, 195 Huang, Y.-B., see Fang, J.-Y. 143, 47 Casals, E., M. Gallardo, J. Estelrich, Factors influencing the Huang, Y.-B., see Wu, P.-C. 143, 119 encapsulation of thioguanine in DRV liposomes _ 143, 171 Cavalli, R., see Trotta, M. 143, 67 lannuccelli, V.,G. Coppi, M. Bondi, M. Pinelli, A. Mingione, Cheskin, H., see Qiu, Y. 143, 179 R. Cameroni, Biodegradable intraoperative system for bone Christensen, F.N., see Jorgensen, K. 143, 223 infection treatment II. In vivo evaluation 143, 187 Coenegracht, P.J.M., see Westerhuis, J.A. 143, 151 lannuccelli, V., G. Coppi, R. Cameroni, Biodegradable intra- Coppi, G., see Iannuccelli, V. 143, 187, 195 operative system for bone infection treatment. I. The drug/ Corrigan, O.I., see Healy, A.M. 143, 211 polymer interaction 143, 195 Ingkatawornwong, S., see Tantishaiyakul, V. 143, 59 de Haan, P., see Westerhuis, J.A. 143, 151 Isshiki, R., see Ueda, H. 143, 37 Deverre, J.-R., see Ramaldes, G.A. 143, | Doelker, E., see Quintanar-Guerrero, D. 143, 133 Jansen, W.T., see Westerhuis, J.A. 143, 151 Jones, D.S., see Medlicott, N.J. 143, 25 Enever, R.P., see Shahjahan, M. 143, 75, 83 Jorgensen, K., F.N. Christensen, Shape modelling of dissolu- Estelrich, J., see Casals, E. 143, 171 tion profiles by non-integer kinetic orders 143, 223 Fang, J.-Y., Y.-B. Huang, P.-C. Wu, Y.-H. Tsai, Transdermal iontophoresis of sodium nonivamide acetate : I. Consider- Kaewnopparat, N., see Tantishaiyakul, V. 143, 59 ation of electrical and chemical factors 143, 47 Farifia, J.B., see Oliva, A. 143, 163 Lehmann, K., see Beckert, T.E. 143, 13 Fattal, E., see Ramaldes, G.A. 143, | Lerk, C.F., see Westerhuis, J.A. 143, 151 Fawcett, J.P., see Stark, G. 143, 93 Lin, H.-H., see Wu, P.-C. 143, 119 Fessi, H., see Quintanar-Guerrero, D. 143, 133 Llabrés, M., see Oliva, A. 143, 163 272 Author index Medlicott, N.J., I.G. Tucker, M.J. Rathbone, D.W. Hol- Shahjahan, M., R.P. Enever, Photolability of nitrofurazone in borow, D.S. Jones, Chlorhexidine release from poly(é- aqueous solution II. Kinetic studies 143, 83 caprolactone) films prepared by solvent evaporation 143, Shahjahan, M., R.P. Enever, Photolability of nitrofurazone in 25 aqueous solution I. Quantum yield studies 143, 75 Mingione, A., see Iannuccelli, V. 143, 187 Simberg, M., see Sintov, A. 143, 101 Morimoto, Y., see Ueda, H. 143, 37 Singhvi, S.M., see Morrison, R.A. 143, 265 Morrison, R.A., S.M. Singhvi, Pharmacokinetics and oral Sintov, A., M. Simberg, A. Rubinstein, Absorption enhance- bioavailability of pravastatin in dogs 143, 265 ment of captopril in the rat colon as a putative method for Moyano, J.R., see Arias-Blanco, M.J. 143, 113 captopril delivery by extended release formulations 143, Moyano, J.R., see Ginés, J.M. 143, 247 101 Mufioz, P., see Arias-Blanco, M.J. 143, 113 Stark, G., J.P. Fawcett, 1.G. Tucker, I.L. Weatherall, Instru- mental evaluation of color of solid dosage forms during Narayani, R., K. Panduranga Rao, Gelatin microsphere cock- stability testing 143, 93 tails of different sizes for the controlled release of anticancer Sugibayashi, K., see Ueda, H. 143, 37 drugs 143, 255 Susan Semla, see Qiu, Y. 143, 179 Novak, C., see Arias-Blanco, M.J. 143, 113 Nystrém, C., see Olsson, H. 143, 233 Tantishaiyakul, V., N. Kaewnopparat, S. Ingkatawornwong, Properties of solid dispersions of piroxicam in polyvinyl- Ogihara, M., see Ueda, H. 143, 37 pyrrolidone K-30 143, 59 Oliva, A., J.B. Farifia, M. Llabrés, Influence of temperature Tan, Y.T.F., see Heng, P.W.S. 143, 107 and shaking on stability of insulin preparations: degradation Trotta, M., R. Cavalli, E. Ugazio, M.R. Gasco, Phase be- kinetics 143, 163 haviour of microemulsion systems containing lecithin and Olsson, H., A. Adolfsson, C. Nystrém, Compaction and lysolecithin as surfactants 143, 67 measurement of tablets in liquids with different dielectric Tsai, Y.-H., see Fang, J.-Y. 143, 47 constants for determination of bonding mechanisms— Tsai, Y.-H., see Wu, P.-C. 143, 119 evaluation of the concept 143, 233 Tucker, I.G., see Medlicott, N.J. 143, 25 Tucker, 1.G., see Stark, G. 143, 93 Panduranga Rao, K., see Narayani, R. 143, 255 Pinelli, M., see Iannuccelli, V. 143, 187 Ueda, H., R. Isshiki, M. Ogihara, K. Sugibayashi, Y. Mori- Puisieux, F., see Ramaldes, G.A. 143, | moto, Combined effect of ultrasound and chemical en- hancers on the skin permeation of aminopyrine 143, 37 Qiu, Y., P. Gupta, J. Briskin, H. Cheskin, Susan Semla, Ugazio, E., see Trotta, M. 143, 67 Sustained-release multiparticulate formulations of Zileuton. I. In vitro and in vivo evaluation 143, 179 Vergnaud, J.M., see Bakhouya, A. 143, 143 Quintanar-Guerrero, D., H. Fessi, E. Allémann, E. Doelker, Influence of stabilizing agents and preparative variables on Wan, L.S.C., see Heng, P.W.S. 143, 107 the formation of poly(D,L-lactic acid) nanoparticles by an Weatherall, I.L., see Stark, G. 143, 93 emulsification-diffusion technique 143, 133 Westerhuis, J.A., P. de Haan, J. Zwinkels, W.T. Jansen, P.J.M. Coenegracht, C.F. Lerk, Optimisation of the compo- Ramaldes, G.A., J.-R. Deverre, J.-M. Grognet, F. Puisieux, E. sition and production of mannitol/microcrystalline cellulose Fattal, Use of an enzyme immunoassay for the evaluation of tablets 143, 151 entrapment efficiency and in vitro stability in intestinal Wu, P.-C., see Fang, J.-Y. 143, 47 fluids of liposomal bovine serum albumin 143, | Wu, P.-C., Y.-B. Huang, H.-H. Lin, Y.-H. Tsai, In vitro Rathbone, M.J., see Medlicott, N.J. 143, 25 percutaneous absorption of captopril through excised rabbit Rubinstein, A., see Sintov, A. 143, 101 skin 143, 119 Wu-Pong, S., J. Bard, Oligonucleotide adsorption to artificial Saidna, M., see Bakhouya, A. 143, 143 surfaces 143, 259 Sanchez-Soto, P.J., see Ginés, J.M. 143, 247 Schmidt, P.C., see Beckert, T.E. 143, 13 Zwinkels, J., see Westerhuis, J.A. 143, 151